Understanding attitudes and obstacles to vaccination against COVID-19 in patients with primary immunodeficiency

BACKGROUND: Patients with primary immunodeficiency (PID) are at increased risk for infections such as SARS-CoV-2 (COVID-19), due to the nature of their diseases and being immunocompromised. At this time, four vaccines against COVID-19 (Pfizer-BioNtech’s Comirnaty(®), Moderna’s Spikevax(®), AstraZene...

Descripción completa

Detalles Bibliográficos
Autores principales: Aberumand, Babak, Ayoub Goulstone, Whitney, Betschel, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083475/
https://www.ncbi.nlm.nih.gov/pubmed/35534860
http://dx.doi.org/10.1186/s13223-022-00679-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083475/
https://www.ncbi.nlm.nih.gov/pubmed/35534860
http://dx.doi.org/10.1186/s13223-022-00679-x

Ejemplares similares